85-5399-45　(6a'R,8a'S,8b'S,9a'R,10a'S,10b'R)-6a',8a'-Dimethyl-8b'-(2-methyl-1,3-dioxolan-2-yl)-1',2',5',6',6a',6b',7',8',8a',8b',9a',10',10a',10b'-tetradecahydrospiro[[1,3]dioxolane-2,4'-naphtho[2',1':4,5]indeno[1,2-b]oxirene] 50mg　439050

特徴

• (6a'R,8a'S,8b'S,9a'R,10a'S,10b'R)-6a',8a'-Dimethyl-8b'-(2-methyl-1,3-dioxolan-2-yl)-1',2',5',6',6a',6b',7',8',8a',8b',9a',10',10a',10b'-tetradecahydrospiro[[1,3]dioxolane-2,4'-naphtho[2',1':4,5]indeno[1,2-b]oxirene] is an intermediate in the synthesis of 16β-Methyl-17α,21-Dihydroxypregna-1,4-diene-3,20-dione (M302195). 16β-Methyl-17α-Dihydroxypregna-1,4-diene-3,20-dione is an intermediate in the synthesis of 17,21-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione (D434280), a corticoid with the potential for ant-inflammatory activity.
• Molecular Formula:C25H36O5
• Solubility:Dichloromethane, Ethyl Acetate
• Molecular Weight:416.55
• Storage and Stability:Store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

仕様

• Size：50mg
• Grade：Highly Purified
• Form：Supplied as a White Solid
• Molecular Formula：C25H36O5
• Molecular Weight Non Ab：416.55
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]